Cargando…

Anti-HIV-1 Activity of Lactic Acid in Human Cervicovaginal Fluid

Women of reproductive age with a Lactobacillus-dominated vaginal microbiota have a reduced risk of acquiring and transmitting HIV and a vaginal pH of ~4 due to the presence of ~1% (wt/vol) lactic acid. While lactic acid has potent HIV virucidal activity in vitro, whether lactic acid present in the v...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tyssen, David, Wang, Ying-Ying, Hayward, Joshua A., Agius, Paul A., DeLong, Kevin, Aldunate, Muriel, Ravel, Jacques, Moench, Thomas R., Cone, Richard A., Tachedjian, Gilda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6034077/ https://www.ncbi.nlm.nih.gov/pubmed/29976641 http://dx.doi.org/10.1128/mSphere.00055-18

Ejemplares similares

Vaginal concentrations of lactic acid potently inactivate HIV
por: Aldunate, Muriel, et al.
Publicado: (2013)

Distinct Immune Responses Elicited From Cervicovaginal Epithelial Cells by Lactic Acid and Short Chain Fatty Acids Associated With Optimal and Non-optimal Vaginal Microbiota
por: Delgado-Diaz, David J., et al.
Publicado: (2020)

Lactic acid from vaginal microbiota enhances cervicovaginal epithelial barrier integrity by promoting tight junction protein expression
por: Delgado-Diaz, David Jose, et al.
Publicado: (2022)

The cervicovaginal mucus barrier to HIV-1 is diminished in bacterial vaginosis
por: Hoang, Thuy, et al.
Publicado: (2020)

Cervicovaginal fluid and semen block the microbicidal activity of hydrogen peroxide produced by vaginal lactobacilli
por: O'Hanlon, Deirdre E, et al.
Publicado: (2010)

Antimicrobial and immune modulatory effects of lactic acid and short chain fatty acids produced by vaginal microbiota associated with eubiosis and bacterial vaginosis
por: Aldunate, Muriel, et al.
Publicado: (2015)

Enhanced Trapping of HIV-1 by Human Cervicovaginal Mucus Is Associated with Lactobacillus crispatus-Dominant Microbiota
por: Nunn, Kenetta L., et al.
Publicado: (2015)

The Impact of Over-The-Counter Lactic Acid Containing Vaginal Gels on the Integrity and Inflammatory State of the Vaginal Epithelium in vitro
por: Tyssen, David, et al.
Publicado: (2022)

IgG in cervicovaginal mucus traps HSV and prevents vaginal Herpes infections
por: Wang, Ying-Ying, et al.
Publicado: (2014)

In vaginal fluid, bacteria associated with bacterial vaginosis can be suppressed with lactic acid but not hydrogen peroxide
por: O'Hanlon, Deirdre E, et al.
Publicado: (2011)

Sialidase Activity in the Cervicovaginal Fluid Is Associated With Changes in Bacterial Components of Lactobacillus-Deprived Microbiota
por: Ferreira, Carolina Sanitá Tafner, et al.
Publicado: (2022)

Vaginal pH and Microbicidal Lactic Acid When Lactobacilli Dominate the Microbiota
por: O’Hanlon, Deirdre E., et al.
Publicado: (2013)

Retroviruses of Bats: a Threat Waiting in the Wings?
por: Hayward, Joshua A., et al.
Publicado: (2021)

Influence of Hormonal Contraceptive Use and HIV on Cervicovaginal Cytokines and Microbiota in Malawi
por: Haddad, Lisa B., et al.
Publicado: (2023)

The implausible “in vivo” role of hydrogen peroxide as an antimicrobial factor produced by vaginal microbiota
por: Tachedjian, Gilda, et al.
Publicado: (2018)

SPL7013 Gel (VivaGel®) Retains Potent HIV-1 and HSV-2 Inhibitory Activity following Vaginal Administration in Humans
por: Price, Clare F., et al.
Publicado: (2011)

Diffusion of Immunoglobulin G in Shed Vaginal Epithelial Cells and in Cell-Free Regions of Human Cervicovaginal Mucus
por: Wang, Ying-Ying, et al.
Publicado: (2016)

Cervicovaginal microbiota and local immune response modulate the risk of spontaneous preterm delivery
por: Elovitz, Michal A., et al.
Publicado: (2019)

Molecular dissection of an inhibitor targeting the HIV integrase dependent preintegration complex nuclear import
por: Wagstaff, Kylie M., et al.
Publicado: (2018)

Identification of Protein Biomarkers for Cervical Cancer Using Human Cervicovaginal Fluid
por: Van Raemdonck, Geert A. A., et al.
Publicado: (2014)

Human cervicovaginal fluid biomarkers to predict term and preterm labor
por: Heng, Yujing J., et al.
Publicado: (2015)

The Interplay Between Cervicovaginal Microbial Dysbiosis and Cervicovaginal Immunity
por: Wang, Ya, et al.
Publicado: (2022)

Three-dimensional models of the cervicovaginal epithelia to study host–microbiome interactions and sexually transmitted infections
por: Edwards, Vonetta L, et al.
Publicado: (2022)

Cervicovaginal mucus barrier properties during pregnancy are impacted by the vaginal microbiome
por: Zierden, Hannah C., et al.
Publicado: (2023)

Citodiagnóstico cervicovaginal /
por: Olvera Rodríguez, Arturo
Publicado: (2009)

"Leucorreas" (cervicovaginitis)/
por: Plácido Islas, María Rebeca
Publicado: (1994)

Identification of diverse full-length endogenous betaretroviruses in megabats and microbats
por: Hayward, Joshua A, et al.
Publicado: (2013)

The Cervicovaginal Microbiota-Host Interaction Modulates Chlamydia trachomatis Infection
por: Edwards, Vonetta L., et al.
Publicado: (2019)

Use of cervicovaginal fluid for the identification of biomarkers for pathologies of the female genital tract
por: Zegels, Geert, et al.
Publicado: (2010)

Identification of Potential Biomarkers in the Cervicovaginal Fluid by Metabolic Profiling for Preterm Birth
por: Ansari, AbuZar, et al.
Publicado: (2020)

Cervicovaginal fluid cytokines as predictive markers of preterm birth in symptomatic women
por: Park, Sunwha, et al.
Publicado: (2020)

Association of HPV infection and clearance with cervicovaginal immunology and the vaginal microbiota
por: Shannon, B, et al.
Publicado: (2017)

Pretreatment of Human Cervicovaginal Mucus with Pluronic F127 Enhances Nanoparticle Penetration without Compromising Mucus Barrier Properties to Herpes Simplex Virus
por: Ensign, Laura M., et al.
Publicado: (2014)

Human cervicovaginal mucus contains an activity that hinders HIV-1 movement
por: Shukair, Shetha A., et al.
Publicado: (2012)

N-glycosylation of cervicovaginal fluid reflects microbial community, immune activity, and pregnancy status
por: Wu, Gang, et al.
Publicado: (2022)

Cervicovaginal cellular angiofibroma
por: Van Mulders, Sarah, et al.
Publicado: (2020)

The Cervicovaginal Mucus Barrier
por: Lacroix, Guillaume, et al.
Publicado: (2020)

A non-optimal cervicovaginal microbiota in pregnancy is associated with a distinct metabolomic signature among non-Hispanic Black individuals
por: Gerson, Kristin D., et al.
Publicado: (2021)

Identifying metabolite markers for preterm birth in cervicovaginal fluid by magnetic resonance spectroscopy
por: Amabebe, Emmanuel, et al.
Publicado: (2016)

Development of a New Biomarker Model for Predicting Preterm Birth in Cervicovaginal Fluid
por: Lee, Ji-Youn, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1ed03h0gnu2eu92gr0153h6avn